China leads in vaccine clinicals
THE first clinical trial of the novel coronavirus vaccine in China has kicked off as volunteers taking part in the project started to share their experience on social media, a Chinese newspaper reported on Saturday.
On Thursday, a female volunteer posted two pictures of her taking the vaccine shot as a part of the phase 1 clinical trial for recombinant novel coronavirus vaccine on China’s Twitter-like social media platform Sina Weibo, according to the Science and Technology Daily.
The clinical trial was filed in the Chinese Clinical Trial Registry on March 17.
According to its registration information, the trial is jointly sponsored by the Institute of Biotechnology, Academy of Military Medical Sciences, People’s Liberation Army and CanSino Biologics Inc based in Tianjin.
The trial is being carried out on healthy adults between the ages of 18 and 60 in two medical facilities in Wuhan, Hubei province. The study is set to be completed by Dec 31, according to the registry.
All 108 volunteers are from Wuhan that was hit hard by the outbreak. They will receive a series of follow-up examinations within six months after injection to see if their bodies have generated antibodies to the virus, the registry said,
Wang Junzhi, a senior expert on drug and vaccine development, said earlier this month that China is simultaneously conducting nine vaccine development projects, and most of them are expected to complete preclinical trials and begin human tests in April. In general, China’s vaccine development against Covid-19 is among the world’s front-runners, he added.